This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07792/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07792/identifier/pubchem-compound/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07792/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07792/identifier/drugbank/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07792/identifier/chemspider/

Statements

Subject Item
n2:DB07792
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07792 n13:DB07792
dcterms:title
(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
adms:identifier
n9:99444263 n10:FRX n11:11987874 n12:10160347 n14:DB07792
n3:IUPAC-Name
n4:271B3FA5-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B3FAB-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B3FAA-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B3FA7-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B3FA8-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B3FA9-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B3FA3-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B3FA1-363D-11E5-9242-09173F13E4C5 n4:271B3FA4-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B3FA2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B3FB1-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B3FB2-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B3FAC-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B3FAD-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B3FAF-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B3FAE-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B3FB0-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B3FB7-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B3FB9-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B3FBA-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B3FB6-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B3FB5-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B3FB8-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B3FA6-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B3FB3-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B3FB4-363D-11E5-9242-09173F13E4C5